Intellectual Property and Licensing

Intellectual Property Strategy
As a technology-driven company, ACROVIS is maximizing its intellectual property rights by consistently integrating its intellectual property strategy into its corporate business strategy. Accordingly, ACROVIS is building a patent portfolio for the protection of both its therapeutic agents, and its diverse platform technologies and bioinformatic tools used in drug discovery processes.

In-Licensing
ACROVIS actively seeks innovations with other companies and universities that will augment its therapeutic development pipeline. We utilize strategic partnerships early in the drug identification process through in-licensing of drug targets.